Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    " October 10, 2012":" November 09, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 10, 2012":" November 09, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Comparison of Two IUDs Among Cape Town HIV-positive Women
Condition: HIV
Interventions: Device: Mirena levonorgestrel IUD;   Device: Copper T-380a IUD
2 Recruiting A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'
Conditions: HIV Positive;   Ageing
Intervention:
3 Not yet recruiting A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
Condition: HCV and HIV Seropositive Coinfection
Interventions: Drug: boceprevir;   Drug: Ribavirin;   Drug: Peginterferon alfa-2a;   Drug: Peginterferon alfa-2b
4 Recruiting Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: EVG/COBI/FTC/TDF
5 Active, not recruiting Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women (WAVES)
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: EVG/COBI/FTC/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: EVG/COBI/FTC/TDF Placebo;   Drug: RTV Placebo;   Drug: ATV Placebo;   Drug: FTC/TDF Placebo
6 Withdrawn A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
Condition: Human Immunodeficiency Virus-Type 1
Intervention: Drug: No intervention
7 Active, not recruiting A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment
Condition: Human Immunodeficiency Virus-type 1 Infection
Interventions: Drug: Rilpivirine;   Drug: Efavirenz;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine
8 Recruiting CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
Condition: Human Immunodeficiency Virus
Interventions: Device: Intervention Arm (computer-based CARE+ Corrections tool);   Other: Educational video on opiate overdose prevention
9 Active, not recruiting Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
10 Completed Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women
Condition: Cervical Intraepithelial Neoplasia
Interventions: Procedure: Cryotherapy;   Procedure: LEEP
11 Completed Comparison of HIV Testing Algorithms
Condition: HIV Infection
Intervention: Other: application of a confirmation test
12 Suspended First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Interventions: Drug: Maraviroc;   Drug: TVD 300/200 QD
13 Completed
Has Results
A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)
Condition: HIV Infection
Interventions: Drug: Raltegravir Film-coated Tablet;   Drug: Raltegravir Chewable Tablet;   Drug: Other Anti-Retroviral Therapy
14 Completed Re-boosting of HIV-1 Infected Subjects With Vacc-4x
Condition: HIV-1 Infection
Intervention: Biological: Vacc-4x
15 Unknown  Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
Conditions: Cocaine-Related Disorders;   HIV;   Heroin Dependence
Interventions: Drug: Methadone;   Drug: Buprenorphine;   Behavioral: Employment-based drug abstinence reinforcement
16 Recruiting Antimalarial Pharmacology in Children and Pregnant Women in Uganda
Conditions: Malaria;   HIV
Intervention:
17 Recruiting Network Supported Engagement In HIV Care
Conditions: HIV;   Patient Acceptance of Health Care
Intervention: Other: Supportive Care
18 Unknown  A Pilot Trial of an Individualized Web-Based Condom Use Intervention
Condition: HIV
Intervention: Behavioral: Condom-HIM
19 Recruiting Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
Conditions: Cryptococcal Meningitis;   HIV
Interventions: Drug: Fluconazole;   Drug: Flucytosine;   Procedure: lumbar punctures
20 Active, not recruiting A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen
Condition: HIV-1 Infection
Interventions: Drug: FZD;   Drug: 3TC;   Drug: EFV;   Drug: AZT

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years